After dismantling the Department of Education, President Donald Trump is turning his attention towards healthcare. Trump is planning to unveil a new proposal for addressing health care costs as soon as Monday, as his administration tries to avert a spike in premiums driven by the expiration of key Affordable Care Act subsidies, three people familiar with the matter told CNN.
A central part of the plan is a renewed push for price transparency, requiring hospitals, clinics, and insurers to clearly disclose the real prices of services, procedures, and negotiated insurance rates. The administration argues that allowing patients to compare costs will create market pressure that lowers overall medical spending.
READ: Big Beautiful Bill’s health care rollback to hit Green Card holders; tighter enforcement alarms H‑1B workers (July 6, 2025)
Senate Republicans agreed to hold a mid-December vote on extending the enhanced subsidies, which are set to lapse at year’s end, in exchange for extending government funding through January, spurring the effort by Trump and his aides to develop their own competing proposal.
Another major component involves prescription drug affordability, especially high-demand treatments such as obesity and chronic-disease medications. Trump has emphasized agreements with major pharmaceutical companies to reduce prices on certain weight-loss drugs and to make future pill-based versions significantly more affordable for uninsured and cash-paying patients.
The Trump administration is still being tight-lipped about their plans. In a statement, a White House official said that “until President Trump makes an announcement himself, any reporting about the Administration’s healthcare positions is mere speculation.”
But reportedly, the framework under discussion envisions temporarily extending the ACA subsidies in some form, while incorporating a series of guardrails aimed at limiting their scope — potentially including new income limits and a requirement that all enrollees pay some form of premium.
Taken together, the plan reflects Trump’s strategy of combining market-driven reforms with targeted agreements between the federal government and pharmaceutical companies. Still, the proposal marks one of the administration’s most ambitious efforts to reshape healthcare affordability in 2025.
The proposal is also likely to include an option for certain enrollees who choose a lower-tier insurance plan on the exchanges to redirect some federal aid into a health savings account, the people familiar said.
Trump’s emerging healthcare proposal signals a broader shift in how his administration is approaching the challenge of rising medical costs and the instability of the insurance market. By combining price transparency measures, negotiations with pharmaceutical companies, and possible adjustments to ACA subsidies, the administration is attempting to balance cost-cutting with consumer choice.
Even though many details remain undisclosed, the framework under discussion may suggest an effort to reshape the healthcare system through a mixture of market incentives and targeted federal intervention. If implemented, the plan could alter how millions of Americans access insurance, compare medical prices, and pay for high-demand medications like weight-loss and chronic-disease drugs.